Gufic Biosciences Limited (GUFICBIO.NS)
INR 316.35
(2.03%)
INR 316.35
(2.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.07 Billion INR | -19.14% |
| 2022 | 3.58 Billion INR | 2.65% |
| 2021 | 3.49 Billion INR | 52.01% |
| 2020 | 2.29 Billion INR | 29.74% |
| 2019 | 1.77 Billion INR | 4.9% |
| 2018 | 1.68 Billion INR | 7.12% |
| 2017 | 1.57 Billion INR | 25.07% |
| 2016 | 1.26 Billion INR | 29.03% |
| 2015 | 977.3 Million INR | 42.33% |
| 2014 | 686.66 Million INR | 23.64% |
| 2013 | 555.39 Million INR | 15.26% |
| 2012 | 481.84 Million INR | 24.81% |
| 2011 | 386.04 Million INR | 11.45% |
| 2010 | 346.37 Million INR | 20.12% |
| 2009 | 288.36 Million INR | 22.31% |
| 2008 | 235.76 Million INR | 14.39% |
| 2007 | 206.1 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 747.21 Million INR | 4.22% |
| 2023 Q1 | 981.8 Million INR | 8.52% |
| 2023 Q4 | 716.97 Million INR | 0.0% |
| 2023 FY | 2.9 Billion INR | -19.14% |
| 2023 Q2 | 1.05 Billion INR | 7.73% |
| 2023 Q3 | 716.97 Million INR | -32.21% |
| 2022 FY | 3.58 Billion INR | 2.65% |
| 2022 Q1 | 877.44 Million INR | 20.12% |
| 2022 Q2 | 894.5 Million INR | 1.94% |
| 2022 Q4 | 904.72 Million INR | -0.72% |
| 2022 Q3 | 911.32 Million INR | 1.88% |
| 2021 FY | 3.49 Billion INR | 52.01% |
| 2021 Q1 | 1.02 Billion INR | 19.73% |
| 2021 Q2 | 892.77 Million INR | -13.31% |
| 2021 Q3 | 842.13 Million INR | -5.67% |
| 2021 Q4 | 730.48 Million INR | -13.26% |
| 2020 FY | 2.29 Billion INR | 29.74% |
| 2020 Q2 | 569.45 Million INR | 130.81% |
| 2020 Q3 | 622.99 Million INR | 9.4% |
| 2020 Q4 | 860.14 Million INR | 38.07% |
| 2020 Q1 | 246.71 Million INR | -35.34% |
| 2019 Q1 | 491.26 Million INR | 6.15% |
| 2019 Q3 | 497.5 Million INR | 23.8% |
| 2019 Q4 | 381.56 Million INR | -23.31% |
| 2019 FY | 1.77 Billion INR | 4.9% |
| 2019 Q2 | 401.85 Million INR | -18.2% |
| 2018 FY | 1.68 Billion INR | 7.12% |
| 2018 Q4 | 462.79 Million INR | 7.03% |
| 2018 Q3 | 432.4 Million INR | 8.88% |
| 2018 Q2 | 397.15 Million INR | 0.12% |
| 2018 Q1 | 396.66 Million INR | -5.46% |
| 2017 FY | 1.57 Billion INR | 25.07% |
| 2017 Q4 | 419.55 Million INR | -4.75% |
| 2017 Q3 | 440.48 Million INR | 14.55% |
| 2017 Q2 | 384.54 Million INR | 21.57% |
| 2017 Q1 | 316.31 Million INR | 7.7% |
| 2016 FY | 1.26 Billion INR | 29.03% |
| 2016 Q3 | 341.41 Million INR | 8.68% |
| 2016 Q1 | 296.9 Million INR | 21.5% |
| 2016 Q2 | 314.14 Million INR | 5.81% |
| 2016 Q4 | 293.7 Million INR | -13.98% |
| 2015 FY | 977.3 Million INR | 42.33% |
| 2015 Q4 | 244.35 Million INR | -8.9% |
| 2015 Q3 | 268.23 Million INR | 6.42% |
| 2015 Q2 | 252.05 Million INR | 18.53% |
| 2015 Q1 | 212.65 Million INR | 30.02% |
| 2014 Q4 | 163.56 Million INR | -6.22% |
| 2014 Q3 | 174.41 Million INR | -1.88% |
| 2014 FY | 686.66 Million INR | 23.64% |
| 2014 Q2 | 177.75 Million INR | 3.99% |
| 2014 Q1 | 170.93 Million INR | 18.93% |
| 2013 Q1 | 120.76 Million INR | 12.89% |
| 2013 FY | 555.39 Million INR | 15.26% |
| 2013 Q2 | 118.5 Million INR | -1.87% |
| 2013 Q4 | 143.72 Million INR | -16.64% |
| 2013 Q3 | 172.4 Million INR | 45.48% |
| 2012 Q4 | 106.97 Million INR | -10.73% |
| 2012 Q2 | 139.88 Million INR | 21.47% |
| 2012 Q3 | 119.82 Million INR | -14.34% |
| 2012 Q1 | 115.15 Million INR | 3.29% |
| 2012 FY | 481.84 Million INR | 24.81% |
| 2011 Q3 | 92.46 Million INR | 0.0% |
| 2011 Q4 | 111.48 Million INR | 20.57% |
| 2011 FY | 386.04 Million INR | 11.45% |
| 2010 FY | 346.37 Million INR | 20.12% |
| 2009 FY | 288.36 Million INR | 22.31% |
| 2008 FY | 235.76 Million INR | 14.39% |
| 2007 FY | 206.1 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aarti Drugs Limited | 8.31 Billion INR | 51.014% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 30.141% |
| Albert David Limited | 1.4 Billion INR | -189.31% |
| Alembic Limited | 1 Billion INR | -307.33% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -32372.961% |
| Hester Biosciences Limited | 1.27 Billion INR | -219.847% |
| Hikal Limited | 5.95 Billion INR | 31.626% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 1.439% |
| Ind-Swift Limited | 2.17 Billion INR | -87.511% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 13.676% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -556.549% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -115.899% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -489.377% |
| Medico Remedies Limited | 262.14 Million INR | -1454.006% |
| Morepen Laboratories Limited | 6.16 Billion INR | 33.882% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 29.537% |
| RPG Life Sciences Limited | 2.48 Billion INR | -64.065% |
| Sigachi Industries Limited | 2 Billion INR | -103.454% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.424% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 1.201% |
| Themis Medicare Limited | 2.42 Billion INR | -68.336% |
| Unichem Laboratories Limited | 4.86 Billion INR | 16.263% |
| Vaishali Pharma Limited | 90.32 Million INR | -4410.183% |
| Venus Remedies Limited | 2.18 Billion INR | -86.647% |
| Windlas Biotech Limited | 1.33 Billion INR | -204.282% |
| ZIM Laboratories Limited | 1.26 Billion INR | -221.32% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 84.789% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -800.963% |
| FDC Limited | 6.58 Billion INR | 38.148% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 79.261% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 15.54% |
| Orchid Pharma Limited | 2.32 Billion INR | -75.569% |
| Alkem Laboratories Limited | 52.29 Billion INR | 92.21% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -176.785% |
| Brooks Laboratories Limited | 65.62 Million INR | -6108.066% |
| Eris Lifesciences Limited | 10.42 Billion INR | 60.93% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 67.234% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 346.013% |
| Innova Captab Limited | 3.46 Billion INR | -17.587% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -524.241% |
| Wanbury Limited | 1.73 Billion INR | -135.388% |
| Lupin Limited | 125.09 Billion INR | 96.744% |
| Sakar Healthcare Limited | 699.58 Million INR | -482.307% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 96.281% |
| Divi's Laboratories Limited | 32.44 Billion INR | 87.442% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 34.534% |
| Mankind Pharma Limited | 42.19 Billion INR | 90.346% |
| Sequent Scientific Limited | 2.97 Billion INR | -36.761% |
| Laurus Labs Limited | 15.44 Billion INR | 73.631% |
| Neuland Laboratories Limited | 8.24 Billion INR | 50.608% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 73.303% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 94.125% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 96.747% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -94.54% |
| Wockhardt Limited | 7.72 Billion INR | 47.231% |
| Bal Pharma Limited | 770.19 Million INR | -428.922% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 97.51% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -10.237% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -669.884% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 55.752% |
| Shilpa Medicare Limited | 3.56 Billion INR | -14.37% |
| Valiant Laboratories Limited | 138.02 Million INR | -2851.36% |
| Ajanta Pharma Limited | 21.06 Billion INR | 80.66% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -3504.148% |
| Granules India Limited | 16.79 Billion INR | 75.751% |
| Medicamen Biotech Limited | 495.49 Million INR | -722.154% |
| Ipca Laboratories Limited | 48.58 Billion INR | 91.615% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -628.099% |
| Piramal Enterprises Limited | 8.04 Billion INR | 49.352% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 91.287% |
| NATCO Pharma Limited | 25.73 Billion INR | 84.171% |
| Suven Life Sciences Limited | -200.79 Million INR | 2128.782% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 3846.065% |
| Strides Pharma Science Limited | 14.38 Billion INR | 71.687% |
| Indoco Remedies Limited | 8.04 Billion INR | 49.351% |
| Alpa Laboratories Limited | 188.89 Million INR | -2056.612% |
| Lasa Supergenerics Limited | 121.02 Million INR | -3265.887% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -941.7% |